Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related PLD
The Top REITs That Mutual Funds Are Buying And Selling
Fund Flows Are Signaling Upside In These Three REIT Stocks
The Vetr community has downgraded $PLD to 4-Stars (Vetr)
Related PXD
Who Wins If America's Oil Export Ban Is Squashed?
Few U.S. Shale Companies Added To Hedges In Q2
The Vetr community has upgraded $PXD to 5-Stars. (Vetr)

Topeka Capital downgraded Pioneer Natural Resources Company (NYSE: PXD) from “buy” to “hold.” The target price for Pioneer Natural Resources Company has been lowered from $200 to $195. Pioneer Natural Resources' shares closed at $184.83 on Friday.

Barclays downgraded GlaxoSmithKline PLC (NYSE: GSK) from “overweight” to “equal-weight.” GlaxoSmithKline's shares closed at $51.41 on Friday.

Analysts at ISI Group downgraded Wynn Resorts (NASDAQ: WYNN) from “buy” to “neutral.” The target price for Wynn Resorts has been raised from $147 to $149. Wynn's shares closed at $150.35 on Friday.

Analysts at Stifel Nicolaus downgraded Prologis (NYSE: PLD) from “buy” to “hold.” Prologis's shares closed at $36.97 on Friday.

Latest Ratings for PLD

Sep 2015Stifel NicolausUpgradesHoldBuy
Sep 2015Evercore PartnersMaintainsBuy
Jul 2015BarclaysMaintainsOverweight

View More Analyst Ratings for PLD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (GSK + PLD)

Get Benzinga's Newsletters